Cargando…
Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
Autores principales: | Lee, Yi Fang, Miller, Lance David, Chan, Xiu Bin, Black, Michael A., Pang, Brendan, Ong, Chee Wee, Salto-Tellez, Manuel, Liu, Edison T., Desai, Kartiki V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369187/ https://www.ncbi.nlm.nih.gov/pubmed/28351428 http://dx.doi.org/10.1186/s13058-017-0830-9 |
Ejemplares similares
-
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
por: Lee, Yi Fang, et al.
Publicado: (2012) -
Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer
por: Soon, Wendy WeiJia, et al.
Publicado: (2011) -
Erratum to: JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI
por: Li, Li-Liang, et al.
Publicado: (2016) -
Erratum: Photogated humidity-driven motility
por: Zhang, Lidong, et al.
Publicado: (2015) -
JMJD6 orchestrates a transcriptional program in favor of endocrine resistance in ER+ breast cancer cells
por: Das, Partha, et al.
Publicado: (2022)